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Vav proteins are guanine nucleotide exchange
factors (GEFs) for Rho family GTPases. They control
processes including T cell activation, phagocytosis,
and migration of normal and transformed cells. We
report the structure and biophysical and cellular
analyses of the five-domain autoinhibitory element
of Vav1. The catalytic Dbl homology (DH) domain of
Vav1 is controlled by two energetically coupled
processes. The DH active site is directly, but weakly,
inhibited by a helix from the adjacent Acidic domain.
This core interaction is strengthened 10-fold by
contacts of the calponin homology (CH) domain
with the Acidic, pleckstrin homology, and DH
domains. This construction enables efficient, step-
wise relief of autoinhibition: initial phosphorylation
events disrupt the modulatory CH contacts, facili-
tating phosphorylation of the inhibitory helix and
consequent GEF activation. Our findings illustrate
how the opposing requirements of strong suppres-
sion of activity and rapid kinetics of activation can
be achieved in multidomain systems.
INTRODUCTION
Vav proteins are guanine nucleotide exchange factors (GEFs) for
small GTPases in the Rho family (Bustelo, 2001; Tybulewicz,
2005). They play important roles in actin regulatory pathways
in numerous cell types and control diverse processes including
immune cell development and activation, neuronal develop-
ment, and angiogenesis. N-terminal truncations of Vav proteins246 Cell 140, 246–256, January 22, 2010 ª2010 Elsevier Inc.lead to cell transformation (Katzav et al., 1989), and the wild-
type proteins have been implicated in the development and
severity of a variety of cancers, including those of the brain,
pancreas, and skin (Dong et al., 2006; Katzav, 2007). Vav1 is
expressed in hematopoietic cells, where it activates the Rac
GTPase in response to Src- and Syk-family kinase signals
downstream of the T cell, B cell, and Fcg receptors. It controls
functions such as the antigen response of T cells, phagocytosis
by macrophages, and superoxide production by neutrophils
(Hall et al., 2006; Tybulewicz, 2005; Utomo et al., 2006). Vav2
and Vav3 aremorewidely expressed and play similarly important
roles in development and cell function throughout the body
(Cowan et al., 2005; Sauzeau et al., 2006).
Vav proteins are composed of eight domains: calponin homol-
ogy (CH), Acidic (Ac), Dbl homology (DH), pleckstrin homology
(PH), zinc finger (ZF), Src homology 3 (SH3), Src homology 2
(SH2), and a second SH3. The DH domain catalyzes guanine
nucleotide exchange in Rho family GTPases (Abe et al., 1999),
and many Vav functions have been ascribed to this activity.
The five N-terminal domains (abbreviated CADPZ; other frag-
ments are designated analogously) function together to regulate
the biochemical activity of the DH domain; the C-terminal Src
homology domains are thought to mediate cellular localization
(Figure 1A) (Bustelo, 2001; Tybulewicz, 2005). The GEF activity
of Vav1 is autoinhibited by binding of a helix from the C terminus
of the Ac domain (residues 167–178) into the active site of the DH
domain, blocking access to substrate (Abe et al., 1999; Aghaza-
deh et al., 2000; Lopez-Lago et al., 2000). This core inhibitory
interaction is relieved by phosphorylation of Tyr174 in the inhibi-
tory helix, which melts the helix and displaces it from the DH
domain (Aghazadeh et al., 2000; Han et al., 1998). In the cell,
Tyr174 is phosphorylated within seconds of receptor stimulation
by Src- and Syk-family kinases, rapidly initiating downstream
signaling. We recently demonstrated that an Ac-DH fragment
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Figure 1. Structural and Energetic Models of Autoinhi-
bition in Vav1
Domains of Vav1 are colored: CH (gold), Ac (red), DH (blue),
PH (green), ZF (magenta), SH3 (white), SH2 (white).
(A) Domain architecture of Vav1 and thermodynamic model for
cooperative inhibition. Solid lines represent direct physical
contacts; dashed line represents thermodynamic coupling
between core and modulatory equilibria.
(B) Schematic representation of autoinhibited CADPZ. Dotted
lines outline C-terminal helix of DH domain lying behind PH
and CH domains.
(C) Ribbon diagram of Vav1 CADPZ. Dashed lines indicate
regions not observed in the electron density map. Side chains
of tyrosines 142, 160, and 174 are shown as sticks. DH active
site is circled. Boxed areas in left and right panels are
expanded in Figures 3A and 3B, respectively.
DPZ element overlay from CADPZ and DPZ/Rac complex
(2vrw) and selective side-chain interactions are shown in
Figure S1. Figure prepared using Pymol (Delano, 2002).of Vav1 rapidly fluctuates between a ‘‘closed’’ ground state,
where the helix is bound to the active site, and an ‘‘open’’ excited
state resembling the phosphorylated form, where the helix is
dissociated and melted (Li et al., 2008). The closed state is
favored by 10:1, and correspondingly this equilibrium
decreases both GEF activity and the rate of Tyr174 phosphoryla-
tion by10-fold, reflecting accessibility of the active site and the
Tyr174 side chain, respectively. Thus, the ratio of the closed and
open states determines the magnitude of autoinhibition and rate
of activation of the helix-DH core.
A variety of data indicate that interactions of the CH domain
further suppress the activity of the DH domain, and that this
suppression is critical for Vav1 function in the cell. For example,
the original vav oncogene encoded a protein lacking part of the
CH domain (Katzav et al., 1989). Later studies showed that CH
truncation increases the transforming activity of Vav1 and its
homolog Vav3, concomitant with increased GEF activity in vitro
and in vivo (Bustelo, 2001; Katzav et al., 1991; Llorca et al.,
2005). A cryoelectron microscopy reconstruction of full-length
Vav3 has suggested that these effects arise from intramolecular
binding of the CH domain to the ZF domain, and to a surface of
the DH domain adjacent to the Ac-helix interface (Llorca et al.,
2005). But this mechanism has not been examined in atomic
resolution structural analyses. Moreover, it is not clear how the
CH interactions affect the helix-DH core to control GEF activity.
Studies of other multidomain systems have shown that the
construction of Vav1, with a core autoinhibitory element whose
biochemical activity is modulated by other domains, is wide-
spread (DiNitto et al., 2007; Moarefi et al., 1997; Prehoda et al.,
2000; Sondermann et al., 2004; Yohe et al., 2008). Thus, under-
standing how cooperativity is achieved in Vav1 should inform
generally on regulation of multidomain proteins.Cell 140Although phosphorylation of Tyr174 is clearly
important to Vav1 activation, several pieces of
data suggest that the process is more complicated
than modification of this single site. In addition to
Tyr174, Vav1 is also phosphorylated at two addi-
tional sites in the N terminus of the acidic element,Tyr142 and Tyr160 upon receptor stimulation (Lopez-Lago et al.,
2000; Miletic et al., 2006). Mutation of these sites increases Vav1
signaling activity, suggesting that they may also contribute to
autoinhibition in the wild-type protein and that their phosphory-
lation could play a role in activation. The mechanisms by which
Tyr142 and Tyr160 contribute to regulation of Vav1, and more
generally the pathway(s) to Vav1 activation, are not understood.
Here we report the structure of the five-domain regulatory
element of Vav1, CADPZ. The structure shows that the CH
domain and the N terminus of the Acidic element bind to each
other and to a platform formed by the PH domain and a
C-terminal extension of the DH domain. Nuclear magnetic reso-
nance (NMR), biochemical, and cell biological analyses show
that these interactions suppress GEF activity by modulating
the core helix-DH equilibrium, shifting it toward the inhibited
state by approximately 10-fold, likely by restraining the inhibitory
helix to the DH domain. Phosphorylation of Tyr142 and Tyr160
relieves the modulatory interactions, making Tyr174 more
accessible to kinases, suggesting a sequential activation mech-
anism for full-length Vav1. The layered construction of Vav1
provides a means of achieving strong suppression of activity
while still maintaining a route to rapid activation, features that
are probably general among multidomain systems in biology.
RESULTS
Structure of Autoinhibited Vav1
To understand how interdomain contacts act together to
suppress GEF activity, and how phosphorylation drives activa-
tion, we determined the crystal structure of the CADPZ element
of Vav1 (Table S1 available online; Figures 1B and 1C) using data
to a resolution of 2.73 A˚. The core module, consisting of the, 246–256, January 22, 2010 ª2010 Elsevier Inc. 247
ECADPZ
L409d
L325d1
25.2
25.4
0.050.100.15
13
C 
(p.
p.m
.)
1H (p.p.m.)
13
C 
(p.
p.m
.) 22.0
22.2
1H (p.p.m.)
0.450.50
CADPZ
N
or
m
al
iz
ed
G
EF
Ac
tiv
ity
A
CA
DP
Z
AD
PZ
CA
DP
ZS6
7D
CA
DP
ZF6
9D
CA
DP
ZK4
87
E
CA
DP
ZF6
9A
CA
DP
ZD4
06
A
0.00
Pak-PBD Pulldown
Ve
cto
r
Va
v1W
T
Va
v1S
67
D
Va
v1Y
17
4D
Va
v1S
67
D/Y
17
4D
Rac1-GTP
Lysate
Total Rac1
Anti-Flag
0.10
0.20
0.30
0.40
0.50
0.60
1.00
1.10
CA
DP
ZY1
74
D
pC
AD
PZ
0.90
C D
B
200
116
66
97
45
31
21
  ADPZY174D
  M
  ADPZ     CADPZ
I W E I W E I W E
CADPZ
ADPZ
GST-Rac
GST
C CC
Figure 2. Vav1 Activity Is Cooperatively Suppressed
through Energetic Coupling of the Core and Modula-
tory Equilibria
(A) Normalized GEF activity of human Vav1 proteins. Error bars
show standard deviation (SD) from three independent
measurements. NMR data showing that phosphorylation
causes dissociation of the CH domain are in Figure S2A.
(B) Immobilized GST-Rac(GDP) was used to pull down the
indicated Vav1 proteins, which were separated by SDS-
PAGE and visualized by Coomassie blue staining. M, I, W, E,
C represent molecular-weight markers, input, final wash,
elution, and elution from control (GST) beads, respectively.
(C) Panc04.03 cells were transfected with a control vector or
the indicated full-length Vav1 expression constructs and
analyzed for Rac1(GTP) using GST-Pak-PBD. Proteins were
resolved by SDS-PAGE and detected by immunoblotting
with the indicated antibodies. Transformation assays of the
same Vav1 proteins are in Figures S2B–S2D.
(D) Overlaid 1H/13C methyl TROSY spectra of a Leu409d
(CH-PH interface) signal in human CADPZ (black), CADPZF69A
(magenta), CADPZF69A/Y174D (cyan), CADPZS67D (green),
CADPZK487E (orange), pCADPZ (red), and ADPZ (blue)
proteins.
(E) Overlaid 1H/13C methyl TROSY spectra of the Leu325d1
resonance (DH-helix interface). Spectra colored as in (D).
In (D) and (E), reporter signals are boxed; dashed lines connect
endpoints. Spectra showing additional NMR signals are in
Figures S2E–S2I.Tyr174-containing inhibitory helix and DH domain, closely
resembles the previously reported solution structure of this
fragment (Aghazadeh et al., 2000). The inhibitory helix lies
perpendicular to the long axis of the DH domain in the bottom
of the active site. The PH and ZF domains dock onto the C
terminus and center of an extended C-terminal helix of the DH
domain, respectively, and make extensive contacts with each
other as well. The organization of the DPZ portion of the structure
closely resembles that seen in recently reported structures of the
DPZ-Rac complex (Chrencik et al., 2008; Rapley et al., 2008).
However, a small bend near the center of the C-terminal DH helix
somewhat changes the relative orientations of the DH domain
and PZ unit in the two structures (Figures S1A and S1B). The
CH domain binds the PH domain and the extended C-terminal
helix of the DH domain but does not contact the ZF domain, in
contrast to previous inferences from electron microscopy (EM)
and biochemical data (Llorca et al., 2005). The CH domain
contacts the helix-DH element only through Arg58 (CH), whose
side chain is near that of Glu169 (helix).
The Ac element emerges from the side of the CH domain
opposite the DH domain. A short N-terminal helix (residues
143–150) wraps around the CH domain and also contacts the
PH domain. This is followed by a long extended element (resi-
dues 151–166) that connects to the inhibitory helix packed in
the DH active site (Figures 1B and 1C). Tyr142 is located imme-
diately before the N-terminal Ac helix; Tyr160 is located in the248 Cell 140, 246–256, January 22, 2010 ª2010 Elsevier Inc.extended element. Both side chains lie on the surface of the
CH domain, with their aromatic rings contacting primarily hydro-
phobic residues (Tyr142: Val30, Gly106, Ile109, Leu145; Tyr160:
Val41, Leu159, Arg63) (Figures S1C and S1D). The hydroxyl
group of Tyr160 forms a hydrogen bond with the side chain of
Asp39 (Figure S1D).
Validation of the Structure by Mutagenesis
The overall domain organization of the structure here is quite
different from the previously reported EM reconstruction of
Vav3, which is 58% identical to Vav1 in amino acid sequence
(see the Extended Experimental Procedures). Most significantly,
the contacts of the CH domain to the PH domain and extended
C-terminal helix of the DH domain are not possible in the
previous description. To validate the organization observed in
the crystal, we mutated a series of residues at different contact
surfaces of the CH domain and compared the GEF activity of
these proteins to several benchmarks. In the wild-type CADPZ
protein, GEF activity is inhibited by the effects of the Acidic helix
on the DH active site and by the modulation of this core interac-
tion by the interdomain contacts of the CH domain (referred to as
modulatory interactions hereafter). Thus, as shown in Figure 2A,
CADPZ has extremely low GEF activity toward Rac. Truncation
of the CH domain (giving the ADPZ protein) results in partial acti-
vation, consistent with the absence of modulatory interactions of
the CH domain but the remaining presence of the core inhibitory
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Figure 3. Interdomain Contacts in Vav1
Domains colored as in Figure 1.
(A) Contacts between CH, PH, and DH domains. Residues discussed in the
text are shown as sticks.
(B) Contacts between CH domain, Ac region, and PH domain. Potential
hydrogen bonds and ionic interactions are shown as dashed lines. Regions
shown in (A) and (B) are boxed in black and red, respectively, in Figure 1C.interaction of the Acidic helix with the DH active site. Phosphor-
ylation of CADPZ at all three tyrosine sites in the Acidic region
(giving pCADPZ) disables both the modulatory and core
elements of the autoinhibitory apparatus (Figure S2A), leading
to maximal GEF activity. GEF activity of fully active (mimicked
by ADPZY174D), partially active (ADPZ), and maximally inhibited
(CADPZ) proteins parallels affinity for Rac, as qualitatively as-
sessed in pull-down assays (Figure 2B), further supporting the
idea that activity reflects accessibility of the DH active site (Li
et al., 2008).
The activities of wild-type CADPZ, ADPZ, and pCADPZ
provide reference points for analysis of a series of CADPZ
mutants. These were designed based on the structure of the
CH-Ac interface with the DPZ element (Figure 3). The CH-Ac
element contacts DPZ through two groups of residues. In the
first group, the a3-a4 loop of the CH domain (residues 66–68)makes parallel b sheet-like interactions with the first b strand of
the PH domain (residues 406–408); interstrand hydrogen bonds
are observed between the side chain of Asp406 and the main
chain NH of Phe69, and Ser67 is immediately adjacent to
Asp406 (Figure 3A). Additional contacts in this region occur
within a hydrophobic cluster that contains Phe69 (CH), Phe425
(PH), Tyr441 (PH), and Phe386 (DH extended helix). The second
interaction group is immediately adjacent, with the N-terminal
helix of the Ac element contacting the basic b5-b6 and b7-a1
loops of the PH domain. Several oppositely charged side chains
are in close proximity across this interface, including Asp150 (Ac)
and Lys487 (PH) (Figure 3B). CADPZmutations S67D, F69D, and
K487Ewere designed to strongly destabilize the b strand, hydro-
phobic cluster, and Ac-PH interactions, respectively. These
CADPZmutants hadGEF activity10%of pCADPZ, very similar
to that of ADPZ, which lacks the CH domain entirely. F69A and
D406A mutations caused smaller increases in GEF activity,
consistent with less severe perturbations of the CH interactions
(Figure 2A). Mutation of Met66, a residue near the CH-PH inter-
face but making no interdomain contacts, had no effect on GEF
activity (not shown). Our crystal structure is also consistent with
the activities of several previously reported CH domain mutants
(Figures S1E–S1G; Table S2).
The GEF activity of Vav1 is also manifest in signaling strength
in cells. Previous reports have shown that overexpression of
Vav1 proteins lacking the CH domain leads to increased Rac
activation and cell transformation (Bustelo, 2001; Han et al.,
1998; Llorca et al., 2005; Lopez-Lago et al., 2000), consistent
with the increased GEF activity of the ADPZ protein. Further
truncation to remove the Ac domain inhibitory helix increases
cellular activity further (Abe et al., 1999), consistent with loss of
the core inhibitory element. As shown in Figure 2C, destabilizing
the modulatory interactions through the S67D mutation also
increases Rac activation in cells. Rac activation is higher in cells
expressing the Y174D helix mutant, consistent with higher GEF
activity of the corresponding CADPZ protein (Figure 2A), and in
the S67D/Y174D double mutant. Similar behavior is observed
in focus-forming assays, where wild-type Vav1 is much less
active than the S67D, Y174D, and double mutants (Figures
S2B–S2D). The similarity in this assay between the threemutants
likely arises because the long timecourse of the assay flattens
differences between partially and fully active proteins. Neverthe-
less these data suggest that the additional modulatory interac-
tions are relevant for the control of Vav activity under nonstimu-
lated conditions. The combined biochemical and biological data
validate the crystal structure and illustrate the importance of the
modulatory contacts in controlling GEF activity in vitro and
in vivo.
Energetic and Structural Mechanisms of Autoinhibition
The data above demonstrate that the modulatory interactions of
the CH and Ac elements with the PH domain further suppress the
GEF activity of the helix-DH core. However, they do not reveal
how this suppression occurs. One possibility is that interactions
of the CH domain shift the autoinhibitory helix-DH equilibrium to
further favor the helix-bound state. That is, the helix-DH equilib-
rium may be thermodynamically coupled to the intramolecular
binding equilibria of the CH domain such that the bound stateCell 140, 246–256, January 22, 2010 ª2010 Elsevier Inc. 249
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Figure 4. Interdomain Cooperativity in Vav1
(A) Overlaid 1H/13C methyl TROSY spectra of murine AsD and CADPZ proteins
(left and right panels, respectively), showing Leu180d1 and Leu325d1 signals
(top and bottom panels, respectively). Colors are as follows: wild-type (WT)
(black), K208A (blue), K208S (yellow), K208G (magenta) mutants and pAsD
or CADPZY174D (red). Relaxation dispersion data for AsD, AD, CAD, CADPZ,
and methyl TROSY spectra showing additional NMR signals are in Figures
S3. Dotted lines connect resonances from phosphorylated and nonphos-
phorylated proteins.
(B) Ratio of open and closed populations (po/pc, average ± SD from 5–8
resonances) of murine AsD (red bars) and CADPZ (black bars) proteins.
(C) Normalized GEF activity of murine AsD (red; previously shown in Li et al.,
2008 and reproduced here by permission from Macmillan Publishers Ltd)
and CADPZ proteins (black). Error bars show SD from three independent
measurements.of one favors the bound state of the other and vice versa.
Although analogous mechanisms have been proposed to
explain interdomain cooperativity in other multidomain systems
(DiNitto et al., 2007; Prehoda et al., 2000; Sondermann et al.,
2004; Young et al., 2001), these hypotheses have not to our
knowledge been tested by direct measurement of the regulatory
equilibria.
To test this hypothesis here, we used NMR to directly examine
the autoinhibitory helix-DH equilibrium in the AsD protein (where
As indicates a shortened Acidic region containing only the inhib-
itory helix) andCADPZ.We recently showed that in AsD the inhib-
itory helix fluctuates in and out of the DH active site on a ms-ms250 Cell 140, 246–256, January 22, 2010 ª2010 Elsevier Inc.timescale, with the helix-bound and helix-free states in an10:1
ratio (Li et al., 2008). These fluctuations are reflected in a large
chemical exchange contribution to transverse relaxation of
NMR signals arising from methyl groups in the protein (large
DR2, the difference betweenmultiple quantum
1H/13C transverse
relaxation measured at the lowest and highest transverse fields;
Figure S3A; Korzhnev et al., 2004). In CADPZ, seven methyl
signals that report on the helix-DH interactions are sufficiently
free of overlap to be analyzed quantitatively: Leu177d1 and
Leu180d1,2 from the helix, Val183g1,2 from the helix-DH linker,
and Leu325d1,2 from the DH domain. DR2 values for all these
methyl groups are significantly reduced in CADPZ (Figure S3A),
indicating a shift in populations toward the helix-bound state,
a change in the fluctuation rate, or both. This reduction in DR2
requires more than addition of the CH domain, as CAD and AD
proteins have very similar values (Figure S3A).
We used a chemical shift-based approach to quantify the pop-
ulations of helix-bound and helix-dissociated states in AsD and
CADPZ. The approach is based on the fact that if a system is
fluctuating rapidly (fast exchange) between two states, then
the chemical shift of any NMR signal will be a population-
weighted average of the chemical shifts of the pure states.
Thus, when the chemical shifts of the pure states are known
(or can be approximated), the chemical shift observed for any
given protein reports on the relative populations of the two states
in equilibrium. Using this approachwe recently showed that a de-
signed series of AsD mutants have different populations of helix-
bound and helix-dissociated states across the autoinhibitory
equilibrium (Li et al., 2008). These proteins ranged from 5%
to >99% open. When their NMR spectra are overlaid, their
signals lie on linear trajectories between those of pAsD and a
nearly completely closed mutant. Three of the mutants, K208A,
K208S, and K208G, populate predominantly the open state of
AsD, with open populations of 74% ± 10%, 83% ± 9%, and
93% ± 6%, respectively (Li et al., 2008). To determine if the
helix-DH equilibrium is different in CADPZ, here we examined
methyl TROSY spectra of CADPZ proteins containing these
same three mutations, as well as a Y174D mutant of CADPZ
(CADPZY174D) that mimics the phosphorylated protein (not
shown). As shown in Figure 4A, methyl chemical shifts from the
helix and DH elements in pAsD and CADPZY174D are nearly iden-
tical, indicating that phosphorylation also shifts the helix-DH
equilibrium in CADPZ to strongly favor the helix-dissociated
state (Figure 4A; Figures S3B–S3D). Similarly, the helix and DH
chemical shifts are in similar positions in AsD and CADPZ.
Thus, the open and closed forms of the helix-DH element are
very similar in AsD and CADPZ. Five of the interface methyl reso-
nances in the CADPZ mutants are in fast exchange and free of
overlap. As in AsD (Li et al., 2008), these resonances lie along
the linear trajectory between the nonphosphorylated and phos-
phorylated chemical shifts (Figure 4A; Figures S3B–S3D). This
linearity indicates that from the standpoint of the inhibitory inter-
face, CADPZ exists in an equilibrium analogous to that in AsD,
fluctuating between helix-bound and helix-dissociated states.
However, for each mutant, the signals in CADPZ are shifted
appreciably toward the nonphosphorylated position relative to
those in AsD. Thus, the core inhibitory equilibrium is shifted
toward the helix-bound state in CADPZ (Figure 4A). These data
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Figure 5. Inhibitory Effects of the CH
Domain Require an Intact Ac Element
Relative GEF activity in titrations of CH proteins
into ADPZ proteins: CH+ADPZ (red circles),
CA+AsDPZ (blue squares). Activities were normal-
ized to those of free ADPZ or AsDPZ. Error bars
represent SD from three independent measure-
ments. Cartoon on the right depicts the corre-
sponding titration reaction. Arrow indicates the
position where the Ac element is cut. NMR titra-
tions and comparison of CH titration into ADPZ
with control experiments are shown in Figures S4.are consistent with the reduction of DR2 in wild-type CADPZ
observed above. The observed chemical shifts indicate that on
average the equilibrium is shifted 10-fold for each mutant
(range = 6- to 16-fold) (Figure 4B). The shift in equilibrium toward
the helix-bound state is also manifest in GEF activity. As in the
AsD proteins (Li et al., 2008), GEF activity of CADPZ is appre-
ciably lower than that of CADPZK208A, reflecting destabilization
of autoinhibitory contacts in the mutant (black bars in Figure 4C).
Most importantly, the activities of the CADPZ proteins are signif-
icantly below those of their AsD counterparts due to the
decreased accessibility of the DH active site (compare black
and red bars in Figure 4C).
These NMR data indicate a thermodynamic mechanism of in-
terdomain cooperativity in which the 10-fold suppression of
accessibility of the DH active site caused by the intrinsic thermo-
dynamics of the AsD core is enhanced an additional 10-fold by
modulatory interactions of the CH domain. How is coupling
between these equilibria achieved structurally? In this regard,
the paucity of contacts between the CH domain and the helix-
DH core element is striking (Figure 1C, right panel). Mutation of
the lone direct CH-DH contact observed in the crystal (R58A)
has no effect on GEF activity in CADPZ (not shown). This
suggests that the CH domain acts on GEF activity in an indirect
manner, perhaps by restraining the N terminus of the Acidic
domain against the DPZ element and consequently entropically
disfavoring the dissociated state of the inhibitory helix. One
prediction of this structural mechanism is that cutting the Acidic
element immediately before the helix should destroy the
mechanical linkage between the modulatory and core elements,
preventing the CH domain from affecting GEF activity. To test
this hypothesis, we performed two titrations, monitoring GEF
activity (Figure 5). In the first, we added CH (residues 1–134) to
ADPZ (residues 135–584), an interaction with a dissociation
equilibrium constant (KD) of 32 mM based on independent NMR
analyses (not shown). As illustrated in Figure 5, the CH domain
can act in trans to suppress GEF activity of ADPZ, with activity
decreasing linearly with the fraction bound. Thus, a protein
cleaved at the CH-Acidic junction can manifest coupling
between the modulatory and core equilibria (see also Figures
S4A–S4C). This effect is specific, as titrations of CHS67D into
ADPZ or CH into ADPZK487E produced much less inhibition
(Figure S4D). In contrast, addition of a CA construct lacking the
inhibitory helix (residues 1–168) to AsDPZ (residues 169–584,
KD = 290 mM) had no effect on GEF activity. Thus, cleaving theAc element before the inhibitory helix prevents the modulatory
equilibrium from communicating to the core equilibrium. In an
analogous titration of CA into deuterated, methyl protonated
AsDPZ, monitored by methyl TROSY spectra of AsDPZ, reso-
nances at the CH-PH interface moved linearly from their posi-
tions in free AsDPZ toward their positions in CADPZ (Figures
S4E and S4F). Thus, the complex reproduced many of the
packing interactions of the intact protein. In the same titration,
resonances at the helix-DH interface were not affected, indi-
cating that the helix-DH equilibrium is not affected by CH-PH
interactions when the Ac element is broken (Figure S4G,
compare to Figure S4C). Thus, the decrease in GEF activity
tracks with modulation of the helix-DH equilibrium, not simply
binding of the CH domain to the PH domain. The data are consis-
tent with the idea that the modulatory interactions act on the
helix-DH equilibrium by restraining the N terminus of the Ac
element, disfavoring dissociation of the helix.
Validation of the Energetic Mechanism by Mutagenesis
To investigate the idea of coupled equilibria in greater detail, we
examined the NMR properties of the proteins described above
(Figure 2A), which are impaired in one or both elements of the
inhibitory apparatus (modulatory or core inhibitory interactions).
For each protein we examined two sets of NMR signals. The first
consists of methyl groups located at the CH-PH interface
(Leu409d1,2, Leu491d, Val102g; Figures 2D; Figures S2E–
S2G). If the CH domain equilibrates rapidly between the state
observed in the crystal structure (with contacts to Ac and PH
intact) and a state where the contacts to Ac and PH are lost,
then the chemical shifts of these methyl signals should reflect
the populations of the two states. This is exactly analogous to
our analysis of the helix-DH equilibrium in Figure 4, under the
assumption that contacts of the CH domain to Ac and PH are
highly cooperative (i.e., CH is either fully bound to both elements
or fully dissociated). When interactions between the CH and PH
domains in CADPZ are destabilized by mutation, these ‘‘CH-PH
signals,’’ which report on stability of the modulatory interactions,
will shift toward the dissociated extreme. The bound extreme is
represented by the CADPZ chemical shifts, and the dissociated
extreme by the chemical shifts of ADPZ or pCADPZ, where the
modulatory contacts are absent or fully destabilized, respec-
tively (Figure 2D; Figure S2A). For each protein we also examined
NMR signals of methyl groups at the helix-DH interface
(Figure 2E; Figures S2H and S2I). As in Figure 4, these signalsCell 140, 246–256, January 22, 2010 ª2010 Elsevier Inc. 251
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Figure 6. Initial Phosphorylation of Tyr142 and Tyr160
Can Provide a Route to Full Vav1 Activation
(A) Normalized GEF activity of human Vav1 proteins. Error
bars represent SD from three independent measurements.
(B) Overlaid 1H/13C methyl TROSY spectra of the
Leu325d1 signal (boxed) in human CADPZ (black), ADPZ
(blue), and CADPZY142D (magenta), CADPZY174D (green),
CADPZY142D/Y160D (gold), pCADPZ (red) proteins. Spectra
showing additional NMR signals and relaxation dispersion
analysis of CADPZ are in Figures S5.
(C) HPLC analysis (with scintillation detection) of tryptic
digests of CADPZ (black) and CADPZY142D/Y160D (red) after
phosphorylation with [g-32P] ATP for 7.5 min. Peaks corre-
sponding to pTyr142-, pTyr160-, and pTyr174-containing
peptides are indicated. At complete phosphorylation, the
peak corresponding to pY174 has virtually identical amplitude
for the two proteins (not shown). HPLC analysis of tryptic
digests of CADPZ and CADPZD39N after phosphorylation
with [g-32P] ATP are in Figures S5.report on populations across the core inhibitory equilibrium. By
comparing CH-PH and helix-DH signals for each mutant, we
can observe how changes to one process affect the other. We
can also correlate both to GEF activity. The behavior of ADPZ
is demonstrative. In this protein the CH-PH signals are strongly
shifted from their CADPZ positions, reflecting the absence of
modulatory interactions. In contrast, since the core inhibitory
module is intact, the helix-DH signals in ADPZ are shifted only
partially from the CADPZ positions toward the pCADPZ posi-
tions (Figure 2E). The GEF activity of ADPZ, which is dependent
on exposure of the DH active site, parallels the helix-DH signals
(Figure 2A). In the CADPZ mutants S67D, F69D, and K487E,
which were designed to destabilize the modulatory interactions,
the CH-PH signals shift appreciably toward their open positions
(Figure 2D). The helix-DH signals shift toward the open position
but remain in the range between the CADPZ and ADPZ positions
(Figure 2E). These changes are consistent with the GEF activities
of these mutants, which are at or below that of ADPZ (Figure 2A).
The less perturbing mutations F69A and D406A show smaller
shifts in the CH-PH signals, much smaller shifts in the helix-DH
signals (Figure 2E), and lower GEF activity (Figure 2A). Thus,
shifting themodulatory equilibrium changes the helix-DH equilib-
rium and consequently GEF activity. Perturbations can also be
observed in reciprocal fashion: introducing the Y174D (helix)
mutation into the F69A background shifts the CH-PH signals
toward their positions in ADPZ (Figure 2D). Thus, destabilizing
the helix-DH interactions also destabilizes the modulatory
interactions. These data support our model that the core and
modulatory equilibria are thermodynamically coupled, and that
this coupling is a major contributor to the cooperative suppres-
sion of GEF activity by interactions of the CH domain.252 Cell 140, 246–256, January 22, 2010 ª2010 Elsevier Inc.Vav1 Activation by Multisite
Phosphorylation
Our model for autoinhibition creates a conundrum
regarding activation of Vav1. That is, how is Tyr174
rapidly accessed by kinases, as is known to occur
in vivo (Miletic et al., 2006), when its exposure is
strongly suppressed by the combined actions ofthe core and modulatory equilibria? We asked whether the
Tyr142 and Tyr160 phosphorylation sites could be important in
providing a kinetic pathway to activation. As shown in Figure 6A,
phosphorylation at Tyr160 or Tyr142 had little effect on GEF
activity. However, the doubly phosphorylated pTyr142/pTyr160
protein has activity similar to ADPZ. To generate materials on
larger scale we mimicked phosphorylation by mutation of
Tyr142 and/or Tyr160 to aspartate. The Tyr to Asp mutants
have GEF activity very similar to their pTyr counterparts, indi-
cating that the mutations act similarly to phosphorylation. The
change in activity of the mutants occurs concomitantly with
a shift in the helix-DH equilibrium toward the ADPZ position as
assessed by NMR (Figure 6B; Figures S5A and S5B). A Y142F/
Y160F double mutant has GEF activity and NMR properties
similar to the double Asp mutant (not shown), explaining
previous data showing that Y142F and Y160F mutations
increase the transforming activity of Vav1 (Lopez-Lago et al.,
2000). These data suggest that initial phosphorylation at
Tyr142 and Tyr160 could destabilize the modulatory interac-
tions, increasing access of Tyr174 to kinases. In support of this
model, Tyr174 is phosphorylated by the Lck kinase domain
much more rapidly in the Y142D/Y160D mutant than in wild-
type CADPZ (Figure 6C). Moreover, in wild-type CADPZ,
Tyr142 and Tyr160 are phosphorylated more rapidly than
Tyr174 (Figure 6C). This is striking because in short peptides
containing the different Vav1 tyrosine motifs, phosphorylation
of Tyr174 is strongly favored over Tyr142 and Tyr160 (Amara-
singhe and Rosen, 2005). These data suggest an ordered
pathway dictated by the structural organization of CADPZ in
which Tyr142 and Tyr160 are modified initially, followed by
Tyr174. Interestingly, mutation of the highly conserved Asp39,
which coordinates the Tyr160 hydroxyl group, to asparagine
decreases both the initial rate of phosphorylation of Tyr160
and also the rate of subsequent phosphorylation of Tyr142 and
Tyr174 (Figure S5C). Thus, Asp39 may be selected to tune the
system into an appropriate response regime.
Tyr142 and Tyr160 would not be accessible to kinases in the
conformation observed in the crystal. However, both side chains
are on the surface of the protein, and NMR relaxation data
indicate substantial ms-ms timescale fluctuations of methyl
groups surrounding them in the Ac element (Figure S5D). These
dynamics likely represent transitions to kinase-accessible
conformations, explaining how Tyr142 and Tyr160 can be phos-
phorylated rapidly. We previously showed that pTyr142 in Ac
peptides provides a docking site for the SH2 domain of the
Lck kinase, and that this interaction allows Lck to phosphorylate
Tyr174 in unimolecular fashion with increased efficiency (4-fold
higher second order catalytic rate constant [kcat/KM]) (Amara-
singhe and Rosen, 2005). Upon initial phosphorylation of
Tyr142/Tyr160, destabilization of modulatory contacts and
recruitment of kinase should act synergistically to increase phos-
phorylation of Tyr174 by Lck. Thus, the structural and energetic
architecture of Vav1 provides a facile kinetic route to activation in
the face of substantial suppression of basal activity. Since
Tyr142 and Tyr160 are conserved in 31 of 33 available Vav
sequences (Aedes aegypti and Tribolium castaneum sequences
have only Tyr142), this mechanism is likely to be general across
the family.
DISCUSSION
Our collective data show that the regulatory apparatus of Vav1 is
composed of at least two thermodynamically coupled processes
(Figure 1A). A core process, in which the inhibitory helix blocks
the DH active site, provides approximately 10-fold suppression
of activity and phosphorylation rate (Li et al., 2008). Binding of
the CH domain to the N terminus of the Acidic element and to
the DPZ fragment restricts the inhibitory helix, thermodynami-
cally coupling these interactions to the core. This coupling shifts
the helix-DH equilibrium 10-fold further toward the inhibited
(helix-bound) state. Together, the two processes provide the
high level of suppression (100-fold) that is apparently needed
for in vivo function (as CH truncation leads to cell transformation;
Bustelo, 2001; Katzav et al., 1991; Llorca et al., 2005). This
10-fold 3 10-fold construction of Vav1 (rather than a single
100-fold inhibitory equilibrium) is likely functionally important,
as we have shown that inhibition by the core alone can be
increased to 50-fold simply by two point mutations (Li et al.,
2008). Biochemical data on other multidomain systems suggest
similar (relatively small, 2- to 20-fold) magnitudes of core
suppression and modulatory coupling (DiNitto et al., 2007;
Moarefi et al., 1997).
This construction has important implications for the biology of
Vav1. It provides a quantitative rationale for the increased activity
of CH domain truncations of the protein. In such truncations,
even though the core inhibitory module is intact, the inherent
thermodynamics of the module produce high levels of the active
state (9%–33%; Figures 2E and 4A; Figure S3A) when coupling
to the modulatory equilibrium is lost. This effect increases boththe phosphorylation rate (and likely steady-state phosphoryla-
tion level) and basal GEF activity of Vav1, explaining increased
Rac activation and cell transformation (Bustelo, 2001; Han
et al., 1998; Llorca et al., 2005; Lopez-Lago et al., 2000). The
ability of CH interactions to modulate the AD core also implies
that molecules that disrupt these contacts could partially
stimulate Vav1 activity and act cooperatively with kinases to fully
activate the protein in vivo.
The creation of suppression from multiple weak interactions
also has important implications regarding the kinetics of Vav1
activation upon receptor stimulation. In many allosteric systems,
it has been shown that activators gain access to their targets by
recognizing the small population of active state present under
basal conditions (Henzler-Wildman and Kern, 2007). This is the
case in the AsD core of Vav1, where kinases can only recognize
Tyr174 in the helix-dissociated state (Li et al., 2008). However,
strong suppression of activity opposes this pathway, as it
requires that the accessible population be very small, which
would tend to make activation slow. The layered energetic and
physical construction of modular proteins provides a likely
general solution to this problem, which we have observed for
Vav1. That is, the structure and energetics of multidomain
systems can be organized so that the modulatory elements are
more accessible to activators (e.g., Tyr142 and Tyr160 in the
CA element show significant ms-ms timescale dynamics and
can be rapidly phosphorylated). This allows activation to occur
in stepwise fashion, with initial events disabling the modulatory
interactions and consequently increasing access to the core.
Thus, modularity enables evolution not only of strong inhibition
but also of ready routes to activation.
A variety of biochemical and structural data suggest that the
energetic and kinetic mechanisms that we have found for Vav1
are likely to be widespread among multidomain proteins. The
Tim family of GEFs represents a structurally and functionally
similar example (Yohe et al., 2008). The Tim proteins have
a DH domain whose activity is inhibited by an adjacent helix
that binds in the active site and that can be displaced by phos-
phorylation, analogous to the Vav AD core. The Tim proteins
also have a C-terminal SH3 domain that further suppresses the
activity of the helix-DH core through binding an internal
proline-rich motif (PRM). The mechanism of suppression by the
SH3 domain has not been explored, but available data would
be consistent with coupling of the helix-DH and SH3-PRM equi-
libria. Moreover, although the kinetic pathway to Tim activation
has not been examined experimentally, it has been speculated
that activation may occur stepwise, with initial displacement of
SH3-PRM interactions facilitating phosphorylation of the inhibi-
tory helix (Yohe et al., 2008). The unrelated Ras GEF, SOS,
also appears to use the same regulatory logic, with the DH-PH
element shifting an allosteric equilibrium in the Rem-Cdc25
element toward its inactive state (Sondermann et al., 2004).
The broadest class of, and best characterized, proteins that
appear to behave in this manner are the protein kinases. A large
body of data suggests that the isolated kinase domain fluctuates
between an inactive state, where the active site is not properly
organized for catalysis, and an active state, where the catalytic
cluster and substrate-binding site are catalytically competent
(e.g., Levinson et al., 2006; Masterson et al., 2008; VogtherrCell 140, 246–256, January 22, 2010 ª2010 Elsevier Inc. 253
et al., 2006). Phosphorylation of residues in the so-called activa-
tion loop stabilizes the active conformation, increasing catalytic
activity. Whereas the active state is common among many
kinases, the inactive states differ. Sampling of the inactive
conformation has been capitalized upon in the Abl tyrosine
kinase inhibitor imatinib, a widely used anticancer therapeutic
(Schindler et al., 2000). Imatinib distinguishes Abl from other
closely related kinases by selectively binding to its unique inac-
tive conformation. NMR analysis of fluctuations between the
active and inactive states in isolated kinase domains is an active
area of research. However, to date such studies have not yielded
a quantitative understanding of kinase thermodynamics (popula-
tions of the states) or a detailed view of the equilibrating struc-
tures in the absence of stabilizing inhibitors (Masterson et al.,
2008; Vajpai et al., 2008; Vogtherr et al., 2006). Many kinases
also contain additional domains that repress the activity of the
catalytic domain (Huse and Kuriyan, 2002). Disabling such
domains, either by truncation or through regulatory interactions,
increases the activity of kinases toward various substrates.
A detailed interpretation of the biochemical data in terms of allo-
steric equilibria is complicated by the fact that phosphorylation
of the activation loop locks the kinase in an active state, and
the activity of nonphosphorylated kinases is very low and thus
hard to quantify. However, molecular dynamics simulations of
the Src kinase have suggested that, at least in that system, the
additional SH3 and SH2 domains suppress activity through
biasing the regulatory equilibrium in the kinase domain toward
the inactive state (Faraldo-Gomez and Roux, 2007; Young
et al., 2001). As in Vav, this construction also appears to dictate
that kinases are activated in stepwise fashion, with initial events
that disable modulatory interactions (e.g., in Src by ligand
binding to the SH3 domain; Moarefi et al., 1997) enabling phos-
phorylation of the activation loop and consequent maximum
stabilization of the active state.
These various examples strongly suggest that although multi-
domain proteins use a variety of structural mechanisms to
achieve regulation, the underlying energetic mechanism that
we have illustrated for Vav, and the requirement for an ordered
activation process that arises from it, are likely to be widely
observed. The NMR approach we developed here provides a
means to directly measure the populations of different states
across regulatory equilibria and has allowed us to quantitatively
characterize the energetic landscape of Vav1. This in turn has es-
tablished coupled equilibria as a major mechanism of interdo-
main cooperativity in this system. Application of these methods
to other systems should reveal how widespread cooperative
inhibition through coupled equilibria is in multidomain proteins.
EXPERIMENTAL PROCEDURES
Generation of Materials
Detailed expression, modification, and purification procedures for all materials
are provided in the Extended Experimental Procedures.
Quantitative Phosphorylation of Tyr142, Tyr160, and Tyr174
We created a murine CADPZ mutant (CADPZtryp) containing three additional
tryptic sites: Arg135, Lys148, and Lys166. Trypsinolysis of CADPZtryp yields
peptides containing Tyr142 (136–148), Tyr160 (149–166), and Tyr174
(167–179). Most NMR signals that report on the core andmodulatory equilibria254 Cell 140, 246–256, January 22, 2010 ª2010 Elsevier Inc.are in identical positions in CADPZ andCADPZtryp (not shown), suggesting that
phosphorylation of CADPZtryp is representative of wild-type. Moreover, bulk
phosphorylation kinetics of CADPZ and CADPZtryp are identical (not shown).
Lck-mediated phosphorylation reactions were carried out with [g32P]ATP,
quenched with the kinase inhibitor LckI2 (Calbiochem #428206), and urea to
8M. Proteins were digested with trypsin. Peptides containing pTyr142,
pTyr160, and pTyr174 were separated with reverse-phase HPLC and detected
by an in-line scintillation counter (Bioscan Flow-Count). See Extended Exper-
imental Procedures for details.
Crystallization and X-Ray Diffraction Data Collection
Crystals of human Vav1 CADPZ (50 3 100 3 200 mm) were grown at 4C
using the hanging-drop vapor-diffusion method. Drops contained 2 ml of
3–10 mg/ml protein solution (20 mM Tris [pH 7.5], 50 mM NaCl, 5% [w/v]
glycerol, 2 mM TCEP) and were equilibrated against 200 ml of water. Crystals
of selenomethionine-labeled protein were obtained under similar conditions
when seeded with native crystals. Crystals were cryoprotected by addition
of ethylene glycol to 30% (v/v). Native and anomalous dispersion data were
collected at 100 K using the Advanced Photon Source 19ID beamline. The
native dataset was collected at the anomalous edge for zinc. Vav1 CADPZ
crystallized in space group P21 with unit cell parameters of a = 85 A˚, b = 59 A˚,
c = 161 A˚, b = 97, containing twomolecules in the asymmetric unit with55%
solvent. Crystals diffracted X-rays to a minimum Bragg spacing of 2.65 A˚.
Data were processed using the HKL3000 suite of programs (Minor et al.,
2006). Data collection statistics are in Table S1.
Phase Determination and Structure Refinement
Phases were obtained from a single-wavelength anomalous dispersion exper-
iment using a seleno-methionine-Vav1 CADPZ crystal with data to a resolution
of 2.80 A˚. Thirty of thirty-four expected selenium sites were located using the
program SHELXD (Schneider and Sheldrick, 2002). Phases were refined with
the program MLPHARE (Otwinowski, 1991), resulting in a figure-of-merit of
0.27. Phases were further improved by density modification and two-fold non-
crystallographic averaging with the program DM (CCP4, 1994) resulting in
a figure-of-merit of 0.88. An initial model containing about 54% of all residues
was automatically generated using the programARP/warp (Morris et al., 2004).
Additional residues were manually added using the program coot (Emsley and
Cowtan, 2004). Refinement was carried out with native data to a resolution of
2.73 A˚ in the program PHENIX (Adams et al., 2002) and consisted of simulated
annealing, conjugate-gradient minimization, and refinement of individual B-
factors and TLS parameters, interspersed with manual revisions of the model.
The current model contains two Vav1 CADPZ monomers (labeled A and B,
respectively) in the asymmetric unit with backbone root-mean-square
deviation (rmsd) of 0.13 A˚ for residues 2–129, 142–150, 156–180, 189–417,
419–456, 463–478, 482–564. Statistics of refinement and structural quality
are listed in Table S1.
NMR Spectroscopy
NMR analyses were performed in buffer containing 20 mM Tris(hydroxy-
methyl-d3)amino-d2-methane, pH 7.5 (uncorrected), 100 mM NaCl, 2 mM
TCEP, and 10% (w/v) d8-glycerol; 99.9% D2O. Data were acquired on 600
and 800 MHz Varian Inova spectrometers equipped with cold probes.
CPMG experiments were performed using a constant relaxation period of
20 ms at 15C. Methyl-TROSY experiments were performed at 25C. Average
open populations (po) for murine proteins were determined as previously
described (Li et al., 2008). Note that po values for AsD reported here differ
slightly from those reported previously due to small differences in buffer condi-
tions. NMR reporters in CADPZ and ADPZwere assigned to residue number by
mutagenesis and confirmed by comparison to spectra of AsD andCAD.Methyl
groups at the helix-DH interface of CADPZ/ADPZ were stereospecifically
assigned by comparison to signals in AsD (Aghazadeh et al., 2000).
Guanine Nucleotide Exchange Assays
Guanine nucleotide exchange assays were carried out and analyzed as previ-
ously described (Li et al., 2008). Assays contained 10 mMVav1CADPZ, AsDPZ,
or ADPZ. In titrations of Figure 5, binding affinities used to calculate fraction
bound (see text) were determined independently under identical solution
conditions through NMR titrations of unlabeled ADPZ proteins into methyl-
labeled CH-containing proteins.
GST-Rac Pull-Down Assays
In each assay, 10 mM GST-Rac (GDP), 10 mM Vav protein, 0.5 mM GDP, 2 mM
MgCl2, and 0.1 M Tris (pH 7.5) were premixed to final volume of 200 ml and
bound to 100 ml glutathione sepharose beads (GE Healthcare). After three
washes, proteins were eluted with 30 mM glutathione. In control experiments,
10 mM GST was used instead of GST-Rac.
Cell-Based Assays
To measure Rac activation by various full-length Vav1 proteins, Panc04.03
pancreatic cancer cells were transfected with 20 mg of pCDNA3 control vector
or Vav1 expression vectors. The GTP-bound form of endogenous Rac1 was
detected using the standard GST-PAK affinity precipitation assay 18 hr
post-transfection (see Extended Experimental Procedures). The transforma-
tion of NIH 3T3 cells was assayed 14 days after transfection with control or
Vav1-expressing pCDNA3.1/HisA vector by staining cells with 0.4% crystal
violet and counting foci (see Extended Experimental Procedures).ACCESSION NUMBERS
The coordinates and structure factors have been deposited in the Protein Data
Bank under accession number 3KY9.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and two tables and can be found with this article online at
doi:10.1016/j.cell.2009.12.033.
ACKNOWLEDGMENTS
We thank Carlos Amezcua and Chad Brautigam for technical assistance,
Lewis Kay for providing NMR pulse sequences, Shae Padrick and Rama
Ranganathan for discussion, and Yuh Min Chook for critical reading of the
manuscript. I.R.S.M. was supported by fellowships from the Foundation for
Science and Technology (Portugal) and the Luso-American Development
Foundation (Portugal). G.K.A. was supported by a postdoctoral fellowship
from the Cancer Research Institute. This work was supported by NIH grants
GM066930 to M.K.R., AI065474 and CA102721 to D.D.B., and CA102721
and CA136526 to M.E.F. and by the Howard Hughes Medical Institute.
D.D.B. is a Leukemia and Lymphoma Society Scholar. Use of the Argonne
National Laboratory Structural Biology Center beamlines at the Advanced
Photon Source was supported by the U.S. Department of Energy, Office of
Energy Research, under Contract No. W-31-109-ENG-38.
Received: May 26, 2009
Revised: October 9, 2009
Accepted: December 17, 2009
Published: January 21, 2010
REFERENCES
Abe, K., Whitehead, I.P., O’Bryan, J.P., and Der, C.J. (1999). Involvement of
NH(2)-terminal sequences in the negative regulation of Vav signaling and
transforming activity. J. Biol. Chem. 274, 30410–30418.
Adams, P.D., Grosse-Kunstleve, R.W., Hung, L.W., Ioerger, T.R., McCoy, A.J.,
Moriarty, N.W., Read, R.J., Sacchettini, J.C., Sauter, N.K., and Terwilliger, T.C.
(2002). PHENIX: building new software for automated crystallographic
structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948–1954.
Aghazadeh, B., Lowry, W.E., Huang, X.Y., and Rosen, M.K. (2000). Structural
basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene
Vav by tyrosine phosphorylation. Cell 102, 625–633.Amarasinghe, G.K., and Rosen, M.K. (2005). Acidic region tyrosines provide
access points for allosteric activation of the autoinhibited Vav1 Dbl homology
domain. Biochemistry 44, 15257–15268.
Bustelo, X.R. (2001). Vav proteins, adaptors and cell signaling. Oncogene 20,
6372–6381.
Chrencik, J.E., Brooun, A., Zhang, H., Mathews, I.I., Hura, G.L., Foster, S.A.,
Perry, J.J., Streiff, M., Ramage, P., Widmer, H., et al. (2008). Structural basis
of guanine nucleotide exchange mediated by the T-cell essential Vav1. J.
Mol. Biol. 380, 828–843.
CCP4 (Collaborative Computational Project, Number 4). (1994). The CCP4
suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystal-
logr. 50, 760–763.
Cowan, C.W., Shao, Y.R., Sahin, M., Shamah, S.M., Lin, M.Z., Greer, P.L.,
Gao, S., Griffith, E.C., Brugge, J.S., and Greenberg, M.E. (2005). Vav family
GEFs link activated Ephs to endocytosis and axon guidance. Neuron 46,
205–217.
Delano, W.L. (2002). The PyMOL Molecular Graphics System DeLano Scien-
tific (CA, USA: San Carlos).
DiNitto, J.P., Delprato, A., Gabe Lee, M.T., Cronin, T.C., Huang, S., Guilherme,
A., Czech, M.P., and Lambright, D.G. (2007). Structural basis and mechanism
of autoregulation in 3-phosphoinositide-dependent Grp1 family Arf GTPase
exchange factors. Mol. Cell 28, 569–583.
Dong, Z., Liu, Y., Lu, S., Wang, A., Lee, K., Wang, L.H., Revelo, M., and Lu, S.
(2006). Vav3 oncogene is overexpressed and regulates cell growth and
androgen receptor activity in human prostate cancer. Mol. Endocrinol. 20,
2315–2325.
Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular
graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132.
Faraldo-Gomez, J.D., and Roux, B. (2007). On the importance of a funneled
energy landscape for the assembly and regulation of multidomain Src tyrosine
kinases. Proc. Natl. Acad. Sci. USA 104, 13643–13648.
Hall, A.B., Gakidis, M.A., Glogauer, M., Wilsbacher, J.L., Gao, S., Swat, W.,
and Brugge, J.S. (2006). Requirements for Vav guanine nucleotide exchange
factors and Rho GTPases in FcgammaR- and complement-mediated phago-
cytosis. Immunity 24, 305–316.
Han, J., Luby-Phelps, K., Das, B., Shu, X., Xia, Y., Mosteller, R.D., Krishna,
U.M., Falck, J.R., White, M.A., and Broek, D. (1998). Role of substrates and
products of PI 3-kinase in regulating activation of Rac-related guanosine
triphosphatases by Vav. Science 279, 558–560.
Henzler-Wildman, K., and Kern, D. (2007). Dynamic personalities of proteins.
Nature 450, 964–972.
Huse, M., and Kuriyan, J. (2002). The conformational plasticity of protein
kinases. Cell 109, 275–282.
Katzav, S. (2007). Flesh and blood: the story of Vav1, a gene that signals in
hematopoietic cells but can be transforming in human malignancies. Cancer
Lett. 255, 241–254.
Katzav, S., Cleveland, J.L., Heslop, H.E., and Pulido, D. (1991). Loss of the
amino-terminal helix-loop-helix domain of the vav proto-oncogene activates
its transforming potential. Mol. Cell. Biol. 11, 1912–1920.
Katzav, S., Martin-Zanca, D., and Barbacid, M. (1989). vav, a novel human
oncogene derived from a locus ubiquitously expressed in hematopoietic cells.
EMBO J. 8, 2283–2290.
Korzhnev, D.M., Kloiber, K., Kanelis, V., Tugarinov, V., and Kay, L.E. (2004).
Probing slow dynamics in high molecular weight proteins by methyl-TROSY
NMR spectroscopy: application to a 723-residue enzyme. J. Am. Chem.
Soc. 126, 3964–3973.
Levinson, N.M., Kuchment, O., Shen, K., Young, M.A., Koldobskiy, M.,
Karplus, M., Cole, P.A., and Kuriyan, J. (2006). A Src-like inactive conformation
in the abl tyrosine kinase domain. PLoS Biol. 4, e144.
Li, P., Martins, I.R., Amarasinghe, G.K., and Rosen, M.K. (2008). Internal
dynamics control activation and activity of the autoinhibited Vav DH domain.
Nat. Struct. Mol. Biol. 15, 613–618.Cell 140, 246–256, January 22, 2010 ª2010 Elsevier Inc. 255
Llorca, O., Arias-Palomo, E., Zugaza, J.L., and Bustelo, X.R. (2005). Global
conformational rearrangements during the activation of the GDP/GTP
exchange factor Vav3. EMBO J. 24, 1330–1340.
Lopez-Lago, M., Lee, H., Cruz, C., Movilla, N., and Bustelo, X.R. (2000).
Tyrosine phosphorylation mediates both activation and downmodulation of
the biological activity of Vav. Mol. Cell. Biol. 20, 1678–1691.
Masterson, L.R., Mascioni, A., Traaseth, N.J., Taylor, S.S., and Veglia, G.
(2008). Allosteric cooperativity in protein kinase A. Proc. Natl. Acad. Sci.
USA 105, 506–511.
Miletic, A.V., Sakata-Sogawa, K., Hiroshima, M., Hamann, M.J., Gomez, T.S.,
Ota, N., Kloeppel, T., Kanagawa, O., Tokunaga, M., Billadeau, D.D., et al.
(2006). Vav1 acidic region tyrosine 174 is required for the formation of T cell
receptor-induced microclusters and is essential in T cell development and
activation. J. Biol. Chem. 281, 38257–38265.
Minor, W., Cymborowski, M., Otwinowski, Z., and Chruszcz, M. (2006).
HKL-3000: the integration of data reduction and structure solution–from
diffraction images to an initial model in minutes. Acta Crystallogr. D Biol.
Crystallogr. 62, 859–866.
Moarefi, I., LaFevre-Bernt, M., Sicheri, F., Huse, M., Lee, C.H., Kuriyan, J., and
Miller, W.T. (1997). Activation of the Src-family tyrosine kinase Hck by SH3
domain displacement. Nature 385, 650–653.
Morris, R.J., Zwart, P.H., Cohen, S., Fernandez, F.J., Kakaris, M., Kirillova, O.,
Vonrhein, C., Perrakis, A., and Lamzin, V.S. (2004). Breaking good resolutions
with ARP/wARP. J. Synchrotron Radiat. 11, 56–59.
Otwinowski, Z. (1991). Isomorphous Replacement and Anomalous Scattering
Proceedings of CCP4 Study Weekend, W. Wolf, P.R. Evans, and A.G.W.
Leslie, eds. (Warrington, UK), pp. 80–86.
Prehoda, K.E., Scott, J.A., Mullins, R.D., and Lim, W.A. (2000). Integration of
multiple signals through cooperative regulation of the N-WASP-Arp2/3
complex. Science 290, 801–806.
Rapley, J., Tybulewicz, V.L., and Rittinger, K. (2008). Crucial structural role for
the PH and C1 domains of the Vav1 exchange factor. EMBO Rep. 9, 655–661.
Sauzeau, V., Sevilla, M.A., Rivas-Elena, J.V., de Alava, E., Montero, M.J.,
Lopez-Novoa, J.M., and Bustelo, X.R. (2006). Vav3 proto-oncogene deficiency256 Cell 140, 246–256, January 22, 2010 ª2010 Elsevier Inc.leads to sympathetic hyperactivity and cardiovascular dysfunction. Nat. Med.
12, 841–845.
Schindler, T., Bornmann, W., Pellicena, P., Miller, W.T., Clarkson, B., and
Kuriyan, J. (2000). Structural mechanism for STI-571 inhibition of abelson tyro-
sine kinase. Science 289, 1938–1942.
Schneider, T.R., and Sheldrick, G.M. (2002). Substructure solution with
SHELXD. Acta Crystallogr. D Biol. Crystallogr. 58, 1772–1779.
Sondermann, H., Soisson, S.M., Boykevisch, S., Yang, S.S., Bar-Sagi, D., and
Kuriyan, J. (2004). Structural analysis of autoinhibition in the Ras activator Son
of sevenless. Cell 119, 393–405.
Tybulewicz, V.L. (2005). Vav-family proteins in T-cell signalling. Curr. Opin.
Immunol. 17, 267–274.
Utomo, A., Cullere, X., Glogauer, M., Swat, W., and Mayadas, T.N. (2006). Vav
proteins in neutrophils are required for FcgammaR-mediated signaling to Rac
GTPases and nicotinamide adenine dinucleotide phosphate oxidase compo-
nent p40(phox). J. Immunol. 177, 6388–6397.
Vajpai, N., Strauss, A., Fendrich, G., Cowan-Jacob, S.W., Manley, P.W.,
Grzesiek, S., and Jahnke, W. (2008). Solution conformations and dynamics
of ABL kinase-inhibitor complexes determined by NMR substantiate the
different binding modes of imatinib/nilotinib and dasatinib. J. Biol. Chem.
283, 18292–18302.
Vogtherr, M., Saxena, K., Hoelder, S., Grimme, S., Betz, M., Schieborr, U.,
Pescatore, B., Robin, M., Delarbre, L., Langer, T., et al. (2006). NMR character-
ization of kinase p38 dynamics in free and ligand-bound forms. Angew. Chem.
Int. Ed. Engl. 45, 993–997.
Yohe, M.E., Rossman, K., and Sondek, J. (2008). Role of the C-terminal SH3
domain and N-terminal tyrosine phosphorylation in regulation of Tim and
related Dbl-family proteins. Biochemistry 47, 6827–6839.
Young, M.A., Gonfloni, S., Superti-Furga, G., Roux, B., and Kuriyan, J. (2001).
Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck
underlies their inactivation by C-terminal tyrosine phosphorylation. Cell 105,
115–126.
